[Synthesis plus absorption inhibitors are useful for high risk patients].
D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use; D002784:Cholesterol / Q000096:biosynthesis; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications* / Q000188:drug therapy*; D007408:Intestinal Absorption / Q000187:drug effects; D012306:Risk
D000924:Anticholesteremic Agents; D001384:Azetidines; D002784:Cholesterol; D000069438:Ezetimibe